Insider trades

Jeff Evanson, Chief Officer of Outlook Therapeutics OTLK, has filed 1 purchase and 4 sales on the open market. The latest trade was on 24/03/20.

Jeff Evanson

Chief Commercial Officer
First filing
23/01/19
Trades
7 trades
Buys / sales
1 / 4
12-month net buying
No record
Last trade
24/03/20

Trading activity

Transactions

Trade type
Open-market buy24/03/0724/03/1162,484 sh$0.42$26,243.28+8.4%
Open-market sale23/01/2023/01/24267,000 sh$1.11$296,370−26.4%
OTLK
Open-market sale23/01/17–23/01/1923/01/19164,155 sh3 trades$1.24avg.$203,725.82−13.9%